KEGG   DRUG: Axicabtagene ciloleucelHelp
Entry
D11144                      Drug                                   

Name
Axicabtagene ciloleucel (USAN);
Yescarta (TN)
Product
Remark
Product: D11144<US>
Efficacy
Antineoplastic, Anti-CD19 CAR-T cell
  Disease
Large B-cell lymphoma
Comment
Cellular therapy product
Target
CD19 [HSA:930] [KO:K06465]
  Pathway
hsa04151  PI3K-Akt signaling pathway
hsa04640  Hematopoietic cell lineage
hsa04662  B cell receptor signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD19
     D11144  Axicabtagene ciloleucel (USAN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D11144
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11144
 Cellular and gene therapy products
  D11144
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11144
BRITE hierarchy
Other DBs
PubChem: 376219068
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system